Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01108913
Recruitment Status : Completed
First Posted : April 22, 2010
Last Update Posted : May 9, 2011
Information provided by:
Revotar Biopharmaceuticals AG